Trimel Pharmaceuticals Stock Price, News & Analysis (TSE:ASP)

C$0.28 0.00 (0.00 %)
(As of 01/17/2018 04:00 PM ET)
Previous CloseC$0.28
Today's RangeC$0.26 - C$0.29
52-Week RangeC$0.10 - C$0.52
Volume146,230 shs
Average Volume254,664 shs
Market CapitalizationC$57.54 million
P/E Ratio-7.00
Dividend YieldN/A
Beta0.36

About Trimel Pharmaceuticals (TSE:ASP)

Trimel Pharmaceuticals logo

Receive ASP News and Ratings via Email

Sign-up to receive the latest news and ratings for ASP and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolTSE:ASP
CUSIPN/A
WebN/A
PhoneN/A

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E Ratio-7
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding Shares213,119,000

Trimel Pharmaceuticals (TSE:ASP) Frequently Asked Questions

What is Trimel Pharmaceuticals' stock symbol?

Trimel Pharmaceuticals trades on the Toronto Stock Exchange (TSX) under the ticker symbol "ASP."

How were Trimel Pharmaceuticals' earnings last quarter?

Trimel Pharmaceuticals Corp. (TSE:ASP) announced its quarterly earnings data on Monday, November, 6th. The company reported ($0.01) earnings per share for the quarter. View Trimel Pharmaceuticals' Earnings History.

When will Trimel Pharmaceuticals make its next earnings announcement?

Trimel Pharmaceuticals is scheduled to release their next quarterly earnings announcement on Tuesday, March, 6th 2018. View Earnings Estimates for Trimel Pharmaceuticals.

Who are some of Trimel Pharmaceuticals' key competitors?

How do I buy Trimel Pharmaceuticals stock?

Shares of Trimel Pharmaceuticals and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is Trimel Pharmaceuticals' stock price today?

One share of Trimel Pharmaceuticals stock can currently be purchased for approximately C$0.28.

How big of a company is Trimel Pharmaceuticals?

Trimel Pharmaceuticals has a market capitalization of C$57.54 million.


MarketBeat Community Rating for Trimel Pharmaceuticals (ASP)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  44 (Vote Outperform)
Underperform Votes:  48 (Vote Underperform)
Total Votes:  92
MarketBeat's community ratings are surveys of what our community members think about Trimel Pharmaceuticals and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Trimel Pharmaceuticals (TSE:ASP) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

Trimel Pharmaceuticals (TSE:ASP) Earnings History and Estimates Chart

Earnings by Quarter for Trimel Pharmaceuticals (TSE:ASP)

Trimel Pharmaceuticals (TSE ASP) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/6/2018        
11/6/2017Q3 2017C($0.01)ViewN/AView Earnings Details
8/11/2017Q2 2017C($0.01)C($0.01)ViewN/AView Earnings Details
5/12/2017Q1 2017C($0.01)C($0.01)ViewN/AView Earnings Details
8/8/2016Q2 2016C$0.04ViewN/AView Earnings Details
5/4/2016Q1 2016C($0.01)C$0.04ViewN/AView Earnings Details
3/2/2016Q4 2015C($0.01)C$0.01ViewN/AView Earnings Details
11/5/2015Q3 2015C($0.01)C$0.01ViewN/AView Earnings Details
8/5/2015Q2 2015C($0.01)C($0.01)ViewN/AView Earnings Details
3/5/2015Q4 2014C($0.02)C($0.05)ViewN/AView Earnings Details
11/6/2014Q3 2014C($0.02)C($0.02)ViewN/AView Earnings Details
7/30/2014Q2 2014C($0.04)C($0.05)ViewN/AView Earnings Details
5/8/2014Q1 2014C($0.04)C($0.02)ViewN/AView Earnings Details
3/5/2014Q4 2013C($0.04)C($0.08)ViewN/AView Earnings Details
11/3/2013Q3 2013C($0.05)C($0.03)ViewN/AView Earnings Details
7/31/2013Q2 2013C($0.05)C($0.07)ViewN/AView Earnings Details
5/8/2013Q1 2013C($0.09)ViewN/AView Earnings Details
3/25/2013Q4 2012C($0.09)C($0.09)ViewN/AView Earnings Details
11/7/2012Q3 2012C($0.09)C($0.07)ViewN/AView Earnings Details
8/7/2012Q2 2012C($0.07)C($0.09)ViewN/AView Earnings Details
5/8/2012Q1 2012C($0.06)C($0.08)ViewN/AView Earnings Details
3/8/2012Q4 2011C($0.06)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Trimel Pharmaceuticals (TSE:ASP) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Trimel Pharmaceuticals (TSE:ASP)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Trimel Pharmaceuticals (TSE ASP) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for Trimel Pharmaceuticals (TSE:ASP)

Trimel Pharmaceuticals (TSE ASP) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/21/2017Kae-Won YoonInsiderBuy196,000C$0.17C$33,320.00
11/17/2017Luc MainvilleDirectorBuy5,100C$0.18C$918.00
11/15/2017Luc MainvilleDirectorBuy2,000C$0.15C$300.00
11/15/2017Philippe Perron SavardInsiderBuy33,000C$0.15C$4,950.00
11/10/2017Luc MainvilleDirectorBuy97,000C$0.14C$13,580.00
11/9/2017Kae-Won YoonInsiderBuy75,000C$0.13C$9,750.00
8/28/2017Stephen Robert GregoryDirectorBuy263,000C$0.12C$31,560.00
6/2/2017Nathan John BrysonInsiderBuy39,000C$0.12C$4,680.00
3/10/2017Nathan John BrysonInsiderBuy100,000C$0.11C$11,000.00
12/6/2016Luc MainvilleDirectorBuy95,000C$0.13C$12,350.00
3/24/2016Ian Orest IhnatowyczDirectorBuy272,000C$0.10C$25,840.00
1/6/2016Eugene MelnykInsiderSell13,000C$0.16C$2,080.00
12/31/2015West Face Capital Inc.InsiderSell520,000C$0.12C$62,400.00
12/30/2015West Face Capital Inc.InsiderSell280,000C$0.14C$40,152.00
12/29/2015Stephen Robert GregoryDirectorBuy28,000C$0.15C$4,200.00
12/29/2015West Face Capital Inc.InsiderSell200,000C$0.14C$28,940.00
12/23/2015Nathan John BrysonInsiderBuy9,000C$0.18C$1,575.00
9/23/2015Stephen Robert GregoryDirectorBuy20,000C$0.40C$8,000.00
9/22/2015Matthew Jonathan PfefferDirectorBuy20,000C$0.40C$8,000.00
9/21/2015Stephen Robert GregoryDirectorBuy7,000C$0.42C$2,905.00
(Data available from 1/1/2013 forward)

Headlines

Trimel Pharmaceuticals (TSE ASP) News Headlines

Source:
DateHeadline
Acerus Enters into a Licensing Agreement with Innovus to Commercialize UriVarx® in CanadaAcerus Enters into a Licensing Agreement with Innovus to Commercialize UriVarx® in Canada
finance.yahoo.com - January 8 at 9:15 AM
Acerus Receives Notice of Deficiency from Health Canada for Gynoflor™Acerus Receives Notice of Deficiency from Health Canada for Gynoflor™
finance.yahoo.com - December 24 at 5:41 PM
Acerus Enters into Loan Facility to Support Anticipated Product Launch and Sales and Marketing Initiatives - Business Wire (press release)Acerus Enters into Loan Facility to Support Anticipated Product Launch and Sales and Marketing Initiatives - Business Wire (press release)
www.businesswire.com - December 7 at 11:30 AM
Acerus Appoints Mr. Mark Lievonen to its Board of Directors - Business Wire (press release)Acerus Appoints Mr. Mark Lievonen to its Board of Directors - Business Wire (press release)
www.businesswire.com - December 7 at 11:30 AM
Acerus Appoints Mr. Mark Lievonen to its Board of DirectorsAcerus Appoints Mr. Mark Lievonen to its Board of Directors
finance.yahoo.com - December 7 at 11:30 AM
Acerus Enters into Loan Facility to Support Anticipated Product Launch and Sales and Marketing InitiativesAcerus Enters into Loan Facility to Support Anticipated Product Launch and Sales and Marketing Initiatives
finance.yahoo.com - December 6 at 11:22 AM
Acerus Secures CDN$1.6 Million of New NATESTO® Orders from Its US Licensee Aytu Bioscience - Business Wire (press release)Acerus Secures CDN$1.6 Million of New NATESTO® Orders from Its US Licensee Aytu Bioscience - Business Wire (press release)
www.businesswire.com - December 1 at 6:13 PM
Acerus Announces Licensing Of NATESTO - Business Wire (press release)Acerus Announces Licensing Of NATESTO - Business Wire (press release)
www.businesswire.com - November 23 at 3:37 PM
Acerus Announces Licensing Of NATESTO® In BrazilAcerus Announces Licensing Of NATESTO® In Brazil
finance.yahoo.com - November 23 at 3:37 PM
Today’s Research Reports on Advanced Proteome Therapeutics, Acerus Pharmaceuticals, BELLUS Health Inc. and Covalon Technologies Ltd.Today’s Research Reports on Advanced Proteome Therapeutics, Acerus Pharmaceuticals, BELLUS Health Inc. and Covalon Technologies Ltd.
finance.yahoo.com - November 23 at 3:37 PM
Acerus Pharmaceuticals Co. (ASP) Insider Purchases C$33,320.00 in StockAcerus Pharmaceuticals Co. (ASP) Insider Purchases C$33,320.00 in Stock
www.americanbankingnews.com - November 21 at 9:34 PM
Acerus Pharmaceuticals Co. (ASP) Director Luc Mainville Acquires 97,000 SharesAcerus Pharmaceuticals Co. (ASP) Director Luc Mainville Acquires 97,000 Shares
www.americanbankingnews.com - November 13 at 8:20 PM
Trimel Pharmaceuticals Corp. (ASP) to Release Earnings on TuesdayTrimel Pharmaceuticals Corp. (ASP) to Release Earnings on Tuesday
www.americanbankingnews.com - November 1 at 10:49 AM
Acerus to Report Third Quarter 2017 Financial Results and Host Investor CallAcerus to Report Third Quarter 2017 Financial Results and Host Investor Call
finance.yahoo.com - October 31 at 3:42 PM
Acerus Announces Licensing of NATESTO® in South East Asian CountriesAcerus Announces Licensing of NATESTO® in South East Asian Countries
finance.yahoo.com - October 17 at 4:57 PM
Extrusion Coating Market worth 5.64 Billion USD by 2022Extrusion Coating Market worth 5.64 Billion USD by 2022
www.marketwatch.com - October 12 at 9:55 PM
Microscopy Market Worth 7.39 Billion USD by 2022Microscopy Market Worth 7.39 Billion USD by 2022
www.marketwatch.com - October 9 at 5:04 PM
Cast Polymers Market Worth 11.97 Billion USD by 2022Cast Polymers Market Worth 11.97 Billion USD by 2022
www.marketwatch.com - October 6 at 4:19 PM
Impopharma Inc. Strengthens Management Team and Board of DirectorsImpopharma Inc. Strengthens Management Team and Board of Directors
www.prnewswire.com - October 5 at 6:58 PM
Acerus Announces Executive Leadership ChangeAcerus Announces Executive Leadership Change
www.thestreet.com - October 2 at 10:05 AM
Life Science Instrumentation Market Worth 75.24 Billion USD by 2022Life Science Instrumentation Market Worth 75.24 Billion USD by 2022
www.marketwatch.com - September 22 at 1:20 PM
Trimel Pharmaceuticals Corp. (ASP) Director Stephen Robert Gregory Acquires 263,000 SharesTrimel Pharmaceuticals Corp. (ASP) Director Stephen Robert Gregory Acquires 263,000 Shares
www.americanbankingnews.com - September 1 at 4:40 PM
Todays Research Reports on GLG Life Tech Corp., Trillium Therapeutics Inc., BELLUS Health Inc. and Acerus Pharmaceuticals CorporationToday's Research Reports on GLG Life Tech Corp., Trillium Therapeutics Inc., BELLUS Health Inc. and Acerus Pharmaceuticals Corporation
finance.yahoo.com - August 18 at 4:12 PM
Acerus to Report Second Quarter 2017 Financial Results and Host Investor CallAcerus to Report Second Quarter 2017 Financial Results and Host Investor Call
finance.yahoo.com - August 4 at 4:28 PM
Trimel Pharmaceuticals Corp. (TSE:ASP) to Release Quarterly Earnings on TuesdayTrimel Pharmaceuticals Corp. (TSE:ASP) to Release Quarterly Earnings on Tuesday
www.americanbankingnews.com - August 1 at 7:17 AM
Daily Coverage on Healthcare Stocks, Valeant Pharma, Knight Therapeutics, and Acerus PharmaDaily Coverage on Healthcare Stocks, Valeant Pharma, Knight Therapeutics, and Acerus Pharma
finance.yahoo.com - July 31 at 4:11 PM
Process Automation & Instrumentation Market Worth 88.92 Billion USD by 2023Process Automation & Instrumentation Market Worth 88.92 Billion USD by 2023
www.marketwatch.com - July 10 at 4:08 PM
FRP Grating Market Worth 574.2 Million USD by 2021FRP Grating Market Worth 574.2 Million USD by 2021
www.prnewswire.com - May 12 at 9:17 PM
George M. Milne Jr., Ph.D., MBAGeorge M. Milne Jr., Ph.D., MBA
www.bloomberg.com - May 12 at 9:17 PM
3 Things In Biotech You Should Learn Today: May 12, 20173 Things In Biotech You Should Learn Today: May 12, 2017
seekingalpha.com - May 12 at 9:17 PM
Q4 2016 Acerus Pharmaceuticals Corporation Earnings Release - Before Market OpenQ4 2016 Acerus Pharmaceuticals Corporation Earnings Release - Before Market Open
biz.yahoo.com - March 8 at 4:21 PM
Q1 2016 Acerus Pharmaceuticals Corporation Earnings Release - Before Market OpenQ1 2016 Acerus Pharmaceuticals Corporation Earnings Release - Before Market Open
biz.yahoo.com - May 4 at 7:07 AM
Q4 2015 Acerus Pharmaceuticals Corporation Earnings Release - Before Market OpenQ4 2015 Acerus Pharmaceuticals Corporation Earnings Release - Before Market Open
biz.yahoo.com - March 2 at 7:07 AM
Q3 2015 Acerus Pharmaceuticals Corporation Earnings Release - Before Market OpenQ3 2015 Acerus Pharmaceuticals Corporation Earnings Release - Before Market Open
biz.yahoo.com - November 5 at 7:07 AM

SEC Filings

Trimel Pharmaceuticals (TSE:ASP) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

Trimel Pharmaceuticals (TSE ASP) Stock Chart for Wednesday, January, 17, 2018

Loading chart…

This page was last updated on 1/17/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.